<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="131637">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01388283</url>
  </required_header>
  <id_info>
    <org_study_id>INMARPE11</org_study_id>
    <nct_id>NCT01388283</nct_id>
  </id_info>
  <brief_title>Inflammatory Markers in Pregnant Women Destined to Develop Preeclampsia</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Oslo University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the predictive role of serum inflammatory markers in
      pregnant women who subsequently develop preeclampsia.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 1999</start_date>
  <completion_date type="Actual">June 2011</completion_date>
  <primary_completion_date type="Actual">May 2004</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">129</enrollment>
  <condition>Preeclampsia</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      serum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Case-control study consisting of 43 women developping preeclampsia and 86 women not
        developping this disorder. All were of Caucasian origin and were nulliparous.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  caucasian,

          -  nulliparous

        Exclusion Criteria:

          -  preexisting cardiovascular diseases,

          -  diabetes,

          -  hypertension,

          -  inflammatory bowel diseases,

          -  serious organ diseases, and

          -  development of separate gestational diabetes and/or hypertension.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>43 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>June 2011</verification_date>
  <lastchanged_date>July 5, 2011</lastchanged_date>
  <firstreceived_date>June 30, 2011</firstreceived_date>
  <responsible_party>
    <name_title>Oslo University Hospital</name_title>
    <organization>Department of Medical Biochemistry</organization>
  </responsible_party>
  <keyword>prognostic marker</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pre-Eclampsia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
